Simplex Trading, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$25.62 - $37.07 $2.22 Million - $3.22 Million	-86,842 Reduced 78.68%	23,534 $837,000
Q3 2023 Nov 01, 2023	BUY	$15.97 - $30.59 $1.72 Million - $3.3 Million	107,831 Added 4236.97%	110,376 $3.28 Million
Q2 2023 Aug 04, 2023	BUY	$15.73 - $23.6 $40,032 - $60,062	2,545 New	2,545 $45,000
Q2 2022 Aug 03, 2022	SELL	$16.49 - $27.64 $620,056 - $1.04 Million	-37,602 Reduced 98.55%	552 $10,000
Q1 2022 May 02, 2022	BUY	$17.15 - $28.31 $306,539 - $506,012	17,874 Added 88.14%	38,154 $837,000
Q4 2021 Feb 23, 2022	BUY	$19.35 - $28.41 $392,418 - $576,154	20,280 New	20,280 $576,000

240

79.5M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.94B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.